Article

AADO expands as more MDs dispense

As the growth of MD dispensing has been steadily increasing within the past few years, the American Association of Dispensing Ophthalmologists Inc. (AADO) has seen a parallel rise in the growth of the organization.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Part 6: Biggest innovations in ophthalmology in 50 years
Part 6: Biggest innovations in ophthalmology in 50 years
Part 5: Biggest innovations in ophthalmology in 50 years
Part 5: Biggest innovations in ophthalmology in 50 years
Part 4: Biggest innovations in ophthalmology in 50 years
Part 4: Biggest innovations in ophthalmology in 50 years
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
Part 3: Biggest innovations in ophthalmology in 50 years
Part 3: Biggest innovations in ophthalmology in 50 years
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
Setting the stage in LA: Neda Shamie, MD, on the 19th Annual Controversies in Modern Eye Care
Part 2: Biggest innovations in ophthalmology in 50 years
Part 2: Biggest innovations in ophthalmology in 50 years
Part 1: Biggest innovations in ophthalmology in 50 years
Part 1: Biggest innovations in ophthalmology in 50 years
(Image credit: Ophthalmology Times) World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
Related Content
Eyestem releases positive results from phase 1 trial in patients with geographic atrophy
April 14th 2025

Eyestem releases positive results from phase 1 trial in patients with geographic atrophy

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

AI reading label system enhances retinal disease diagnosis and training in ophthalmology
April 13th 2025

AI reading label system enhances retinal disease diagnosis and training in ophthalmology

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Study finds geographic and institutional disparities for DR and DME clinical trials
April 12th 2025

Study finds geographic and institutional disparities for DR and DME clinical trials

Vantage Biosciences doses first patient in phase 2 study of VX-01, oral therapy for non-proliferative diabetic retinopathy
April 11th 2025

Vantage Biosciences doses first patient in phase 2 study of VX-01, oral therapy for non-proliferative diabetic retinopathy

© 2025 MJH Life Sciences

All rights reserved.